Barrow, Hanley, Mewhinney & Strauss’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CLX
Barrow, Hanley, Mewhinney & Strauss's CLX Position: Q2 2026 in Review
Barrow, Hanley, Mewhinney & Strauss reduced its Clorox (CLX) stake by 4% in Q2 2026, selling an estimated $431K and leaving 106,377 shares worth $10.2M. The position accounts for 0.03% of the portfolio, ranked #150.
Barrow, Hanley, Mewhinney & Strauss first reported a position in CLX in Q1 2026 and has held it in 2 quarters since. The position peaked at $11.5M in Q1 2026. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Barrow, Hanley, Mewhinney & Strauss held 106,377 shares of Clorox worth $10.2M as of Q2 2026.
- Barrow, Hanley, Mewhinney & Strauss sold 4,486 Clorox shares in Q2 2026, an estimated $431K.
- Clorox made up 0.03% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #150 holding.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Clorox in Q1 2026 and has held it in 2 quarters since.
- Barrow, Hanley, Mewhinney & Strauss's Clorox position peaked at $11.5M in Q1 2026.
- 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.